Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- AED 18.58T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | AED 36.5B | AED 241.39 | 4.81% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | AED 30.3B | AED 436.92 | 2.02% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | AED 17.7B | AED 313.66 | 1.82% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | AED 30.2B | AED 462.66 | 1.04% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | AED 31.5B | AED 1,125.71 | 0.47% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | AED 26.4B | AED 189.17 | 0.28% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | AED 17B | AED 102.29 | 3.30% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | AED 21.9B | AED 1,096.94 | 1.65% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | AED 35.3B | AED 371.34 | 7.78% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | AED 28.6B | AED 170.38 | 2.07% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | AED 16.7B | AED 152.22 | 1.42% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | AED 55.8B | AED 286.59 | 1.60% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | AED 17.4B | AED 49.67 | 2.63% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | AED 17.9B | AED 103.02 | 0.72% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | AED 22.3B | AED 340.98 | 0.97% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | AED 17.8B | AED 185.57 | 1.13% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | AED 23.8B | AED 351.17 | 0.73% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | AED 18.4B | AED 220.74 | 0.43% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | AED 34.4B | AED 1,480.25 | 4.49% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | AED 58.3B | AED 907.53 | 2.65% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | AED 27.3B | AED 249.62 | 3.00% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | AED 22.5B | AED 159.47 | 1.00% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | AED 19.4B | AED 459.21 | 0.49% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | AED 43.6B | AED 225.14 | 4.77% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | AED 14.4B | AED 105.48 | 2.25% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | AED 49.3B | AED 98.61 | 3.87% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | AED 96.8B | AED 441.18 | 1.43% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | AED 102.7B | AED 141.81 | 0.26% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | AED 25.9B | AED 492.89 | 1.29% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | AED 11.5B | AED 59.43 | 0.43% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | AED 27.4B | AED 348.70 | 0.18% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | AED 30.9B | AED 38.60 | 1.50% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | AED 26.9B | AED 306.90 | 1.78% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | AED 65.2B | AED 993.63 | 0.24% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | AED 90.6B | AED 2,127.36 | 0.84% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | AED 128.1B | AED 315.24 | 2.82% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | AED 73.1B | AED 545.41 | 5.11% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | AED 23.2B | AED 571.51 | 1.34% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | AED 27.9B | AED 80.10 | 3.27% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | AED 86.7B | AED 75.66 | 0.73% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | AED 45.9B | AED 55.07 | 1.39% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | AED 180.6B | AED 154.81 | 1.10% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | AED 587.7B | AED 103.11 | 1.39% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | AED 448.3B | AED 219.34 | 2.66% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | AED 146.4B | AED 254.60 | 0.93% up | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | AED 359.3B | AED 3,473.04 | 1.27% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | AED 500.5B | AED 1,974.06 | 0.61% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | AED 116.1B | AED 188.27 | 1.35% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | AED 169.5B | AED 1,484.14 | 2.22% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | AED 664.9B | AED 383.92 | 0.17% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | AED 1.24T | AED 504.48 | 4.20% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | AED 1.85T | AED 1,048.47 | 2.51% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | AED 21B | AED 30.92 | 2.43% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | AED 638.2B | AED 144.80 | 3.13% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | AED 4.52T | AED 5,070.61 | 2.47% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | AED 358.2B | AED 178.72 | 1.18% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | AED 2.42T | AED 1,004.18 | 1.90% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | AED 416.3B | AED 173.37 | 0.68% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | AED 1.08T | AED 569.23 | 2.60% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | AED 1.02T | AED 655.78 | 2.04% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | AED 249.7B | AED 78.16 | 1.66% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of AED 18.58T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.